During AHA 2024, data were presented from the Phase III trial of plozasiran targeting adults with genetically or clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback